Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 10,000 shares at $20.06 ($200K) on 2022-10-03, disclosed to the SEC on 2022-10-05.
Open-market sale of $200k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.06 | 5,000 | $100K | 50.1% |
| 2 | $20.00 | 5,000 | $100K | 49.9% |
| Total | $20.03 avg | 10,000 | $200K | 100% |
| Filing → |
| DAWN | SELL | 2023-01-04 | $1.0M | — | Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |